Literature DB >> 15372466

Hormonal regulation of the Grb14 signal modulator and its role in cell cycle progression of MCF-7 human breast cancer cells.

Rania Kairouz1, Jayamala Parmar, Ruth J Lyons, Alexander Swarbrick, Elizabeth A Musgrove, Roger J Daly.   

Abstract

Growth factor receptor bound (Grb)14 is a member of the Grb7 family of src homology (SH)2 domain-containing proteins. These proteins perform both adaptor and modulatory roles in receptor tyrosine kinase (RTK) signaling, although their regulation is poorly understood. In this study, a positive correlation between Grb14 protein expression and ER alpha status in breast cancer cell lines led us to investigate regulation of Grb14 by estradiol and insulin, which synergize in the regulation of breast cancer cell proliferation. In MCF-7 cells maintained in charcoal-stripped serum, Grb14 expression was downregulated by estradiol and increased by the pure anti-estrogen ICI 182780. Under serum-free conditions, insulin enhanced Grb14 expression but this effect was repressed by estradiol when both hormones were used in combination. Using a system in which c-Myc induction drives cell cycle progression independently of estradiol, we demonstrated that Grb14 regulation was specific to estradiol treatment. Finally, we demonstrated a novel functional role for Grb14 whereby its overexpression inhibited not only insulin- but also estrogen-induced cell cycle progression. This was associated with decreased extracellular signal-regulated kinase (Erk)1/2 activation in insulin-stimulated Grb14-overexpressing cells. These data represent the first demonstration of regulation of Grb14 expression levels in response to hormonal stimuli, and are consistent with its role as a repressor of insulin signaling where it is induced as a negative feedback mechanism. A role for Grb14 is also shown in estrogen/insulin crosstalk since estradiol blocks the insulin-induced induction of this protein. 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15372466     DOI: 10.1002/jcp.20199

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  9 in total

1.  Molecular determinants of Grb14-mediated inhibition of insulin signaling.

Authors:  Diana Goenaga; Cornelia Hampe; Nadège Carré; Katia Cailliau; Edith Browaeys-Poly; Dominique Perdereau; Lowenna J Holt; Roger J Daly; Jean Girard; Isabelle Broutin; Tarik Issad; Anne-Françoise Burnol
Journal:  Mol Endocrinol       Date:  2009-04-09

2.  Role of RNA binding protein HuR in ductal carcinoma in situ of the breast.

Authors:  Mira Heinonen; Annabrita Hemmes; Kaisa Salmenkivi; Kotb Abdelmohsen; Suvi-Tuuli Vilén; Marko Laakso; Marjut Leidenius; Tuula Salo; Sampsa Hautaniemi; Myriam Gorospe; Päivi Heikkilä; Caj Haglund; Ari Ristimäki
Journal:  J Pathol       Date:  2011-04-11       Impact factor: 7.996

Review 3.  Grb10 and Grb14: enigmatic regulators of insulin action--and more?

Authors:  Lowenna J Holt; Kenneth Siddle
Journal:  Biochem J       Date:  2005-06-01       Impact factor: 3.857

Review 4.  The role of the basal stem cell of the human breast in normal development and cancer.

Authors:  Jose Russo; Irma H Russo
Journal:  Adv Exp Med Biol       Date:  2011       Impact factor: 2.622

5.  Long-term estrogen exposure promotes carcinogen bioactivation, induces persistent changes in gene expression, and enhances the tumorigenicity of MCF-7 human breast cancer cells.

Authors:  Barbara C Spink; James A Bennett; Brian T Pentecost; Nicole Lostritto; Neal A Englert; Geoffrey K Benn; Angela K Goodenough; Robert J Turesky; David C Spink
Journal:  Toxicol Appl Pharmacol       Date:  2009-07-18       Impact factor: 4.219

6.  Significant association of estrogen receptor binding site variation with bipolar disorder in females.

Authors:  Lisette Graae; Robert Karlsson; Silvia Paddock
Journal:  PLoS One       Date:  2012-02-28       Impact factor: 3.240

7.  Effects of combined treatment with rapamycin and cotylenin A, a novel differentiation-inducing agent, on human breast carcinoma MCF-7 cells and xenografts.

Authors:  Takashi Kasukabe; Junko Okabe-Kado; Nobuo Kato; Takeshi Sassa; Yoshio Honma
Journal:  Breast Cancer Res       Date:  2005-11-09       Impact factor: 6.466

Review 8.  The role of small adaptor proteins in the control of oncogenic signalingr driven by tyrosine kinases in human cancer.

Authors:  Cécile Naudin; Clément Chevalier; Serge Roche
Journal:  Oncotarget       Date:  2016-03-08

9.  Genomic organization and control of the grb7 gene family.

Authors:  E Lucas-Fernández; I García-Palmero; A Villalobo
Journal:  Curr Genomics       Date:  2008-03       Impact factor: 2.236

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.